Conclusion
A number of peptides derived from the large chromogranin precursor proteins have been identified in neuroendocrine tissues and several of them have been attributed with functional data. In addition, various fragments were shown to be liberated by the action of prohormone convertases. This is in accordance with the concept that these peptides represent the mediators of at least part of the yet unidentified physiological functions of the chromogranins.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
Similar content being viewed by others
References
Aardal, S., Helle, K.B., Elsayed, S., Reed, R.K., and Serck-Hanssen, G., 1993, Vasostatins, comprising the N-terminal domain of chromogranin A, suppress tension in isolated human blood vessel segments. J. Neuroendocrinol. 5: 405–412.
Agneter, E., Sitte, H.H., Stöckl-Hiesleitner, S., Fischer-Colbrie, R., Winkler, H., and Singer, E.A., 1995, Sustained dopamine release induced by secretoneurin in the striatum of the rat: a microdialysis study. J. Neurochem. 65: 622–625.
Anouar, Y., Desmoucelles, C., Yon, L., Leprince, J., Breault, L., Gallo-Payet, N., and Vaudry, H., 1998, Identification of a novel secretogranin 11-derived peptide (SgII187-252) in adult and fetal human adrenal glands using antibodies raised against the human recombinant peptide. J. Clin. Endocrinol. Metab. 83: 2944–2951.
Bauer, R., Ischia, R., Marksteiner, J., Kapeller, I., and Fischer-Colbrie, R., 1999a, Localization of neuroendocrine secretory protein 55 messenger RNA in the rat brain. Neuroscience 91: 685–694.
Bauer, R., Weiss, C., Marksteiner, J., Doblinger, A., Fischer-Colbrie, R., and Laslop, A., 1999b, The new chromogranin-like protein NESP55 is preferentially localized in adrenaline-synthesizing cells of the bovine and rat adrenal medulla Neurosci. Lett. 263: 13–16.
Conlon, J.M., Hamberger, B., and Grimelius, L., 1992, Isolation of peptides arising from the specific posttranslational processing of chromogranin A and chromogranin B from human pheochromocytoma tissue. Peptides 13: 639–644.
Curry, W.J., Shaw, C., Johnston, C.F., Thim, L., and Buchanan, K.D., 1992, Isolation and primary structure of a novel chromogranin A-derived peptide, WE-14, from a human midgut carcinoid tumour. FEBS Lett. 301: 319–321.
Dillen, L., Miserez, B., Claeys, M., Aunis, D., and De Potter, W.P., 1993, Posttranslational processingof proenkephalinsandchromogranins/secretogranins. Neurochem. Int. 22: 315–352.
Dittié, A.S., and Tooze, S.A., 1995, Characterization of the endopeptidase PC2 activity towards secretogranin II in stably transfected PC12 cells. Biochem. J. 310: 777–787.
Drees, B.M., Rouse, J., Johnson, J., and Hamilton, J.W., 1991, Bovine parathyroid glands secrete a 26-kDa N-terminal fragment of chromogranin-A which inhibits parathyroid cell secretion. Endocrinology 129: 3381–3387.
Eskeland, N.L., Zhou, A., Dinh, T.Q., Wu, H., Parmer, R.J., Mains, R.E., and O’Connor, D.T., 1996, Chromogranin A processing and secretion: specific role of endogenous and exogenous prohonnone convertases in the regulated secretory pathway. J. Clin. Invest. 98: 147–156.
Fasciotto, B.H., Gorr, S.U., DeFranco, D.J., Levine, M.A., and Cohn, D.V., 1989, Pancreastatin, a presumed product of chromogranin-A (secretory protein-I) processing, inhibits secretion from porcine parathyroid cells in culture. Endocrinology 125: 1617–1622.
Fasciotto, B.H., Trauss, C.A., Greeley, G.H., and Cohn, D.V., 1993, Parastatin (porcine chromogranin A347-4199), a novel chromogranin A-derived peptide, inhibits parathyroid cell secretion. Endocrinology 133: 461–466.
Fischer-Colbrie, R., Laslop, A., and Kirchmair, R., 1995, Secretogranin 11: molecular properties, regulation of biosynthesis and processing to the neuropeptide secretoneurin. Prog. Neurobiol. 46: 49–70.
Flanagan, T., Taylor, L., Poulter, L., Viveros, O.H., and Diliberto, E.J., Jr., 1990, A novel 1745-dalton pyroglutamyl peptide derived from chromogranin B is in the bovine adrenomedullary chromaffin vesicle. Cell. Mol. Neurobiol. 10: 507–523.
Hayward, B.E., Kamiya, M., Strain, L., Moran, V., Campbell, R., Hayashizaki, Y., and Bonthron, D.T., 1998, The human GNASI gene is imprinted and encodes distinct paternally and biallelically expressed G proteins. Proc. Natl. Acad. Sci. USA 95: 10038–10043.
Hoflehner, J., Eder, U., Laslop, A., Seidah, N.G., Fischer-Colbrie, R., and Winkler, H., 1995, Processing of secretogranin II by prohomone convertases: importance of PCl in generation of secretoneurin. FEBSLett. 360: 294–298.
Iacangelo, A.L., and Eiden, L.E., 1995, Chromogranin A current status as a precursor for bioactive peptides and a granulogenic/sorting factor in the regulated secretory pathway. Regul. Pept. 58: 65–88.
Ischia, R., Lovisetti-Scamihorn, P., Hogue-Angeletti, R., Wolkersdorfer, M., Winkler, H., and Fischer-Colbrie, R., 1997, Molecular cloning and characterization of NESP55, a novel chromogranin-like precursor of a peptide with5-HT1B receptor antagonist activity. J. Biol. Chem. 272: 11657–11662.
Kirchmair, R., Hogue-Angeletti, R., Gutirrez, J., Fischer-Colbrie, R., and Winkler, H., 1993, Secretoneurin — a neuropeptide generated in brain, adrenal medulla and other endocrine tissues by proteolytic processing of secretogranin II (chromogranin C). Neuroscience 53: 359–365.
Kirchmair, R., Leitner, B., Fischer-Colbrie, R., Marksteiner, J., Hogue-Angeletti, R., and Winkler, H., 1995, Large variations in the proteolytic formation of a chromogranin A-derived peptide (GE-25) in neuroendocrine tissues. Biochem. J. 310: 331–336.
Kroesen, S., Marksteiner, J., Leitner, B., Hogue-Angeletti, R., Fischer-Colbrie, R., and Winkler, H., 1996, Rat brain: distribution of immunoreactivity of PE-11, a peptide derived from chromogranin B. Eur. J. Neurosci. 8: 2679–2689.
Laslop, A., Weiss, C., Savaria, D., Eiter, C., Tooze, S.A., Seidah, N.G., and Winkler, H., 1998, Proteolytic processing of chromogranin B and secretogranin II by prohormone convertases. J. Neurochem. 70: 374–383.
Lazure, C., Benjannet, S., Seidah, N.G., and Chrétien, M., 1991, Processed forms of neuroendocrine proteins 7B2 and secretogranin II are found in porcine pituitary extracts. Int. J. Pept. Protein Res. 38: 392–400.
Leitner, B., Fischer-Colbrie, R., Scherzer, G., and Winkler, H., 1996, Secretogranin II: relative amounts and processing to secretoneurin in various rat tissues. J. Neurochem. 66: 1312–1317.
Leitner, B., Lovisetti-Scamihom, P., Heilmann, J., Striessnig, J., Blakely, R.D., Eiden, L.E., and Winkler, H., 1999, Subcellular localization of chromogranins, calcium channels, amine carriers, and proteins of the exocytotic machinery in bovin esplenic nerve. J. Neurochem. 72: 1110–1116.
Li, J.Y., Leitner, B., Lovisetti-Scamihom, P., Winkler, H., and Dahlström, A., 1999, Proteolytic processing, axonal transport and differential distribution of chromogranins A and B, and secretogranin II (secretoneurin) in rat sciatic nerve and spinal cord. Eur. J. Neurosci. 11: 528–544.
Li, J.Y., Leitner, B., Winkler, H., and Dahlström, A., 1998, Distribution of chromogranins A and B and secretogranin II (secretoneurin) in rat pelvic neurons and vas deferens. Neuroscience 84: 281–294.
Liang, F., Li, J.Y., Lovisetti-Scamihom, P., Coen, E., Depreitere, J., Claeys, M., Wechsung, E., Dahlström, A., Winkler, H., and De Potter, W.P., 1999, The processing of secretogranin II in the periheral nervous system: release of secretoneurin from porcine sympathetic nerve terminals. Brain Res. 818: 459–467.
Lovisetti-Scamihom, P., Fischer-Colbrie, R., Leitner, B., Scherzer, G., and Winkler, H., 1999a, Relative amounts and molecular forms ofNESP55 in various bovine tissues. Brain Res. 829: 99–106.
Lovisetti-Scamihom, P., Liang, F., Leitner, B., De Potter, W., and Winkler, H., 1999b, Pig splenic nerve: peptides derived from chromogranins by proteolytic processing during axonal transport. Regul. Pept. 79: 63–67.
Mahata, S.K., O’Connor, D.T., Mahata, M., Yoo, S.H., Taupenot, L., Wu, H., Gill, B.M., and Parmer, R.J., 1997, Novel autocrine feedback control of catecholamine release. A discrete chromogranin A fragment is a noncompetitive nicotinic cholinergic antagonist. J. Clin. Invest. 100: 1623–1633.
Muller, L., and Lindberg, I., 1999, The cell biology of the prohormone convertases PCl and PC2. Prog.Nucleic Acid Res. Mol. Biol. 63: 69–108.
Parmer, R.J., Miles, L.A., Xi, X.-P., Gill, B.M., Wu, H.-J., and O’Connor, D.T., 1993, Processing of chromaffin granule proteins: a profusion of proteases? Neurochem. Int. 22: 361–367.
Perone, M.J., and Castro, M.G., 1997, Prohormone and proneuropeptide synthesis and secretion, Histol. Histopathol. 12: 1179–1188.
Peters, J., Wroe, S.F., Wells, C.A., Miller, H.J., Bodle, D., Beechey, C.V., Williamson, C.M., and Kelsey, G., 1999, A cluster of oppositely imprinted transcripts at the Gnas locus in the distal imprinting region of mouse chromosome 2. Proc. Natl. Acad. Sci. USA 96: 3830–3835.
Reinisch, N., Kirchmair, R., Kähler, C.M., Hogue-Angeletti, R., Fischer-Colbrie, R., Winkler, H., and Wiedermann, C.J., 1993, Attraction of human monocytes by the neuropeptide secretoneurin. FEBS Lett. 334: 41–44.
Rosa, P., and Gerdes, H.H., 1994, The granin protein family: markers for neuroendocrine cells and tools for the diagnosis ofneuroendocrine tumors. J. Endocrinol. Invest. 17: 207–225.
Saria, A., Troger, J., Kirchmair, R., Fischer-Colbrie, R., Hogue-Angeletti, R., and Winkler, H., 1993, Secretoneurin releases dopamine from rat striatal slices: a biological effect of a peptide derived from secretogranin II (chromogranin C). Neuroscience 54: 1–4.
Seidah, N.G., Day, R., Marcinkiewicz, M., and Chretien, M., 1998, Precursor convertases: an evolutionary ancient, cell-specific, combinatorial mechanism yielding diverse bioactive peptides and proteins. Ann. NY Acad. Sci. 839: 9–24.
Sigafoos, J., Chestnut, W.G., Merrill, B.M., Taylor, L.C.E., Diliberto, E.J., Jr., and Viveros, O.H., 1993, Novel peptides from adrenomedullary chromaffin vesicles. J. Anat. 183: 253–264.
Strub, J.-M., Garcia-Sablone, P., Lonning, K., Taupenot, L., Hubert, P., Van Dorsselaer, A., Aunis, D., and Metz-Boutigue, M.H., 1995, Processing of chromogranin B in bovine adrenal medulla. Identification of secretolytin, the endogenous C-terminal fragment of residues 614–626 with antibacterial activity. Eur. J. Biochem. 229: 356–368.
Strub, J.-M., Goumon, Y., Lugardon, K., Capon, C., Lopez, M., Moniatte, M., Van Dorsselaer, A., Aunis, D., and Metz-Boutigue, M.H., 1996, Antibacterial activity of glycosylated and phosphorylated chromogranin A-derived peptide 173–194 from bovine adrenal medullary chromaffin granules. J. Biol. Chem. 271: 28533–28540.
Tatemoto, K., Efendic, S., Mutt, V., Makk, G., Feistner, G.J., and Barchas, J.D., 1986, Pancreastatin, a novel pancreatic peptide that inhibits insulin secretion. Nature 324: 476–478.
Udupi, V., Lee, H.M., Kurosky, A., and Greeley, G.H., Jr., 1999, Prohormone convertase-1 is essential for conversion ofchromogranin A to pancreastatin. Regul. Pept. 83: 123–127.
Van Horssen, A.M., and Martens, G.J.M., 1999, Biosynthesis of secretogranin II in Xenopus intermediate pituitary. Mol. Cell. Endocrinol. 147: 57–64.
Vaudry, H., and Conlon, J.M., 1991, Identification of a peptide arising from the specific post-translation processing of secretogranin II. FEBS Lett. 284: 31–33.
Watkinson, A., Jonsson, A.C., Davison, M., Young, J., Lee, C.M., Moore, S., and Dockray, G.J., 1991, Heterogeneity of chromogranin A-derived peptides in bovine gut, pancreas and adrenal medulla. Biochem. J. 276: 471–479.
Watkinson, A., and Robinson, I., 1992, Reserpine-induced processing of chromogranin A in cultured bovine adrenal chromaffin cells. J. Neurochem. 58: 877–883.
Weiss, U., Ischia, R., Eder, S., Lovisetti-Scarnihorn, P., Bauer, R., and Fischer-Colbrie, R., 2000, NESP55: Alternative splicing onto GNAS transcripts and posttranslational processing of a maternally expressed protein. Neuroendocrinology: in press.
Winkler, H., and Fisher-Colbrie, R., 1992, The chromogranins A and B: the first 25 years and future Perspectives. Neuroscience 49: 497–528.
Wolkersdorfer, M., Laslop, A., Lazure, C., Fisher-Colbrie, R., and Winkler, H., 1996, Processing of chromogranins in chromaffin cell culture: effects of reserpine and a-methyl-p-tyrosine. Biochem. J. 316: 953–958.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2002 Kluwer Academic Publishers
About this chapter
Cite this chapter
Laslop, A., Doblinger, A., Weiss, U. (2002). Proteolytic Processing of Chromogranins. In: Helle, K.B., Aunis, D. (eds) Chromogranins. Advances in Experimental Medicine and Biology, vol 482. Springer, Boston, MA. https://doi.org/10.1007/0-306-46837-9_12
Download citation
DOI: https://doi.org/10.1007/0-306-46837-9_12
Publisher Name: Springer, Boston, MA
Print ISBN: 978-0-306-46446-1
Online ISBN: 978-0-306-46837-7
eBook Packages: Springer Book Archive